Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis

[1]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[2]  D. Choi,et al.  Ions, cell volume, and apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Y Ishizaki,et al.  Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Palmieri,et al.  Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia. , 2000, Leukemia research.

[5]  P. Golstein.  FasL Binds Preassembled Fas , 2000, Science.

[6]  C. Bortner,et al.  Protein Kinase C (PKC) Inhibits Fas Receptor-induced Apoptosis through Modulation of the Loss of K+ and Cell Shrinkage , 2000, The Journal of Biological Chemistry.

[7]  J K Frederiksen,et al.  Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. , 2000, Science.

[8]  D. Lawrence,et al.  Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.

[9]  H. Zhu,et al.  Cloning and Functional Identification of a Neuronal Glutamine Transporter* , 2000, The Journal of Biological Chemistry.

[10]  A. Signore,et al.  Identification and Characterization of a Ligand-independent Oligomerization Domain in the Extracellular Region of the CD95 Death Receptor* , 1999, The Journal of Biological Chemistry.

[11]  G. Evan,et al.  c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. , 1999, Genes & development.

[12]  Y. Aizawa,et al.  Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation , 1999 .

[13]  E. Solary,et al.  Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs* , 1999, The Journal of Biological Chemistry.

[14]  M. Amylon,et al.  Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study , 1999, Leukemia.

[15]  G. Griffiths,et al.  Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells , 1999, Nature Medicine.

[16]  G. Gores,et al.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.

[17]  A. Fornace,et al.  Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1 , 1998, Oncogene.

[18]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[19]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[20]  T. Ko,et al.  Glutamine deprivation induces apoptosis in intestinal epithelial cells. , 1998, Surgery.

[21]  H. Müller,et al.  Use of L-asparaginase in childhood ALL. , 1998, Critical reviews in oncology/hematology.

[22]  F. Lang,et al.  Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Sheridan,et al.  Identification of a ligand for the death-domain-containing receptor Apo3 , 1998, Current Biology.

[24]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[25]  M. Moreno,et al.  Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins. , 1998, Journal of immunology.

[26]  P. Scheurich,et al.  Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction , 1998, Current Biology.

[27]  Thomas A. Luger,et al.  Ultraviolet Light Induces Apoptosis via Direct Activation of CD95 (Fas/APO-1) Independently of Its Ligand CD95L , 1998, The Journal of cell biology.

[28]  G. Evan,et al.  Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. , 1997, Science.

[29]  T. Ueno,et al.  Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase , 1997, Leukemia.

[30]  A. Chinnaiyan,et al.  Ultraviolet Radiation-induced Apoptosis Is Mediated by Activation of CD-95 (Fas/APO-1)* , 1997, The Journal of Biological Chemistry.

[31]  B. Dörken,et al.  Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells , 1997, Leukemia.

[32]  V. Dixit,et al.  A Novel Family of Viral Death Effector Domain-containing Molecules That Inhibit Both CD-95- and Tumor Necrosis Factor Receptor-1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[33]  E. Newsholme,et al.  Aspects of glutamine metabolism in human tumour cells , 1997, Biochemistry and molecular biology international.

[34]  J. Bertin,et al.  Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Stephen J. Elledge,et al.  Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.

[36]  Michael Karin,et al.  Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.

[37]  G. Guidotti,et al.  Cell susceptibility to apoptosis by glutamine deprivation and rescue: Survival and apoptotic death in cultured lymphoma‐leukemia cell lines , 1996, Journal of cellular physiology.

[38]  C. Bortner,et al.  Absence of volume regulatory mechanisms contributes to the rapid activation of apoptosis in thymocytes. , 1996, The American journal of physiology.

[39]  H. Jürgens,et al.  Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. , 1996, European journal of cancer.

[40]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[41]  P. Krammer,et al.  Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteases , 1995, European journal of immunology.

[42]  V. Dall’Asta,et al.  Response of human fibroblasts to hypertonic stress. Cell shrinkage is counteracted by an enhanced active transport of neutral amino acids. , 1994, The Journal of biological chemistry.

[43]  L. Filgueira,et al.  Exogenous glutamine requirement is confined to late events of T cell activation , 1993, Journal of cellular biochemistry.

[44]  H. Mikawa,et al.  The Inhibition of Lymphocyte Blastogenesis by Asparaginase: Critical Role of Glutamine in both T and B Lymphocyte Transformation , 1992, Acta paediatrica Japonica : Overseas edition.

[45]  G. Guidotti,et al.  Amino Acid Transporters: Systematic Approach and Principles of Control , 1992 .

[46]  D. Häussinger,et al.  Mammalian Amino Acid Transport , 1992, Springer US.

[47]  G. Guidotti,et al.  Role of Amino Acid Transport System A in the Control of Cell Volume in Cultured Human Fibroblasts , 1991 .

[48]  H. Mikawa,et al.  Metabolic basis for differential glutamine requirements of human leukemia cell lines , 1990, Journal of cellular physiology.

[49]  U. Stephani,et al.  Electrolytes, Amino Acids and Proteins in Lumbar CSF during the Treatment of Acute Leukemia in Childhood , 1990, Acta paediatrica Scandinavica.

[50]  E. Newsholme,et al.  The effect of glutamine concentration on the activity of carbamoyl-phosphate synthase II and on the incorporation of [3H]thymidine into DNA in rat mesenteric lymphocytes stimulated by phytohaemagglutinin. , 1989, The Biochemical journal.

[51]  E. Roth,et al.  Asparaginase‐induced derangements of glutamine metabolism: the pathogenetic basis for some drug‐related side‐effects , 1988, European journal of clinical investigation.

[52]  M. Ardawi.  Glutamine and glucose metabolism in human peripheral lymphocytes. , 1988, Metabolism: clinical and experimental.

[53]  R. Law,et al.  Are ninhydrin‐positive substances volume‐regulatory osmolytes in rat renal papillary cells? , 1987, The Journal of physiology.

[54]  K. Brand.  Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. , 1985, The Biochemical journal.

[55]  H. R. Zielke,et al.  Glutamine: a major energy source for cultured mammalian cells. , 1984, Federation proceedings.

[56]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[57]  D C Teller,et al.  Physical properties of antitumor glutaminase-asparaginase from Pseudomonas 7A. , 1976, The Journal of biological chemistry.

[58]  A. Spiers,et al.  Bacterial glutaminase in treatment of acute leukaemia. , 1976, British medical journal.

[59]  J. Roberts.  Purification and properties of a highly potent antitumor glutaminase-asparaginase from Pseudomonas 7Z. , 1976, The Journal of biological chemistry.

[60]  H. G. Windmueller,et al.  Uptake and metabolism of plasma glutamine by the small intestine. , 1974, The Journal of biological chemistry.

[61]  H. Morris,et al.  The role of glutamine in the oxidative metabolism of malignant cells. , 1972, Cancer research.

[62]  W. Dolowy,et al.  Isolation, crystallization, and properties of Achromobacteraceae glutaminase-asparaginase with antitumor activity. , 1972, The Journal of biological chemistry.

[63]  D. Herbert,et al.  A new L-asparaginase with antitumour activity? , 1968, Lancet.

[64]  L. Mashburn,et al.  TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI. , 1964, Archives of biochemistry and biophysics.